AG
PTCT icon

Advisor Group’s PTC Therapeutics PTCT Stock Holding History

Advisor Group’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$33K Sell
704
-95
-12% -$4.04K ﹤0.01% 3681
2019
Q3 		$27K Buy
799
+250
+46% +$10.9K ﹤0.01% 3773
2019
Q2 		$25K Hold
549
– – ﹤0.01% 3836
2019
Q1 		$21K Hold
549
– – ﹤0.01% 3954
2018
Q4 		$19K Buy
549
+49
+10% +$1.76K ﹤0.01% 3842
2018
Q3 		$24K Hold
500
– – ﹤0.01% 3781
2018
Q2 		$17K Hold
500
– – ﹤0.01% 3809
2018
Q1 		$14K Hold
500
– – ﹤0.01% 3892
2017
Q4 		$8K Hold
500
– – ﹤0.01% 4218
2017
Q3 		$10K Hold
500
– – ﹤0.01% 3969
2017
Q2 		$9K Hold
500
– – ﹤0.01% 3987
2017
Q1 		$5K Buy
+500
New +$6.05K ﹤0.01% 4119

Other funds holding PTCT

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Advisor Group's PTCT Position: Q4 2019 in Review

Advisor Group reduced its PTC Therapeutics (PTCT) stake by 12% in Q4 2019, selling an estimated $4.04K and leaving 704 shares worth $33K. The position accounts for ﹤0.01% of the portfolio, ranked #3681.

Advisor Group first reported a position in PTCT in Q1 2017 and has held it in 12 quarters since. 206 funds tracked by Wall St. Rank hold PTCT as of Q4 2019.

  • Advisor Group held 704 shares of PTC Therapeutics worth $33K as of Q4 2019.
  • Advisor Group sold 95 PTC Therapeutics shares in Q4 2019, an estimated $4.04K.
  • PTC Therapeutics made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #3681 holding.
  • Advisor Group first reported a position in PTC Therapeutics in Q1 2017 and has held it in 12 quarters since.
  • 206 funds tracked by Wall St. Rank held PTC Therapeutics as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.